Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: J Magn Reson Imaging. 2017 Nov 27;47(6):1692–1700. doi: 10.1002/jmri.25897

Table 2.

Pathology grade and stage for all cancers. IDC= invasive ductal carcinoma. ILC = invasive lobular carcinoma. DCIS = ductal carcinoma in situ.

Type N = 187
Invasive Carcinoma 146/187 (78.0%)
IDC 137/187 (73.3%)
 Low grade  26/137 (18.9%)
 Intermediate grade  50/137 (36.5%)
 High grade  70/137 (51.1%)
ILC 9/187 (4.8%)
 Low grade  0/9 (0.0%)
 Intermediate grade  6/9 (66.7%)
 High grade  3/9 (33.3%)
Carcinoma in Situ
DCIS 41/187 (21.9%)
 Low grade  2/41 (4.9%)
 Intermediate grade  15/41 (36.6%)
 High grade  24/41 (58.5%)
Stage at diagnosis N = 162
 0 (in situ)  32/162 (19.8%)
 IA  69/162 (42.6%)
 IB  2/162 (1.2%
 IIA  25/162 (15.4%)
 IIB  7/162 (4.3%)
 IIIA  15/162 (9.3%)
 IIIB  2/162 (1.2%)
 IIIC  2/162 (1.2%)
 IV  6/162 (3.7%)
 Final staging unavailable  2/162 (1.2%)